Study of Speech and Voice Biomarkers Linked to Burnout in Healthcare Workers Using the Calmigo Stress Management Device

What This Trial Is About

Researchers are studying how speech and voice characteristics can help detect signs of burnout and stress in healthcare workers, including physicians, nurses, advanced practice providers, and other clinical staff at the Minneapolis Heart Institute. The study evaluates the relationship between voice features collected from speech samples and mental stress or burnout as measured by questionnaires. It also compares the effects of using the CalmiGo stress management device against no specific guidance on these voice features and burnout levels. Participants are divided into two groups one uses the CalmiGo device three times daily for three minutes each session over 12 weeks, and the other receives no intervention. During the study, speech and voice samples are collected and analyzed, and participants complete questionnaires assessing burnout and mental stress. The study runs in parallel groups, with random assignment to either the device or no intervention, aiming to observe changes over 12 weeks. Participants complete speech and voice recordings and fill out burnout questionnaires at the start and end of the study. Researchers measure burnout using the Mini-Z 2.0 survey and the Maslach Burnout Inventory over the 12-week period. The study monitors participants ability to consistently use the device and complete questionnaires while tracking changes in voice features and reported stress levels. The trial is expected to conclude in October 2027.

Evaluation of Speech and Voice Biomarkers in Association With Burnout